529 filings
4
Aleksandra Rizo
16 May 24
Syndax Pharmaceuticals / Aleksandra Rizo ownership change
4:04pm
3
Aleksandra Rizo
16 May 24
Syndax Pharmaceuticals / Aleksandra Rizo ownership change
4:03pm
8-K
SNDX
Syndax Pharmaceuticals Inc
15 May 24
Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors
4:11pm
10-Q
2024 Q1
SNDX
Syndax Pharmaceuticals Inc
Quarterly report
8 May 24
7:04am
8-K
SNDX
Syndax Pharmaceuticals Inc
8 May 24
Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update
7:03am
ARS
wpoxtqo01n 1bqi6es
2 Apr 24
Annual report to shareholders
4:30pm
DEFA14A
kc7ukf lqyn
2 Apr 24
Additional proxy soliciting materials
4:02pm
8-K
2bspvfsynkw6jpzf2ko
18 Mar 24
Syndax Announces Appointment of Steven Closter as Chief Commercial Officer
7:10am
S-3ASR
a2erf cx1
27 Feb 24
Automatic shelf registration
5:28pm
S-8
gjeji4b
27 Feb 24
Registration of securities for employees
5:21pm
8-K
s648ytk3 p39m4
27 Feb 24
Syndax Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update
4:03pm
SC 13G
csyxqrc
14 Feb 24
Syndax Pharmaceuticals / Kynam Capital Management ownership change
12:50pm
SC 13G/A
gab0y60rlqa
14 Feb 24
Syndax Pharmaceuticals / Point72 Asset Management ownership change
7:01am
SC 13G/A
bb03q4eexid 8l8zatue
13 Feb 24
Syndax Pharmaceuticals / Avidity Partners Management ownership change
9:44pm
SC 13G
qroxj24 dj7vm2zc
13 Feb 24
Syndax Pharmaceuticals / VANGUARD ownership change
5:15pm
4
ko406p7t
9 Feb 24
Syndax Pharmaceuticals / Michael A Metzger ownership change
4:05pm
4
e7vkev86 del04m
9 Feb 24
Syndax Pharmaceuticals / Keith A. Goldan ownership change
4:05pm
4
hblejrjxrr 5maocj
9 Feb 24
Syndax Pharmaceuticals / Neil Gallagher ownership change
4:05pm